These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 17989706)
1. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells. Tomihara K; Kato K; Masuta Y; Nakamura K; Uchida H; Sasaki K; Tanaka T; Huang J; Hiratsuka H; Hamada H Gene Ther; 2008 Feb; 15(3):203-13. PubMed ID: 17989706 [TBL] [Abstract][Full Text] [Related]
2. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154. Loskog A; Tötterman TH; Böhle A; Brandau S Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026 [TBL] [Abstract][Full Text] [Related]
3. Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells. Tomihara K; Kato K; Masuta Y; Nakamura K; Tanaka T; Hiratsuka H; Hamada H Int J Cancer; 2007 Apr; 120(7):1491-8. PubMed ID: 17205529 [TBL] [Abstract][Full Text] [Related]
4. Prospects for CD40-directed experimental therapy of human cancer. Tong AW; Stone MJ Cancer Gene Ther; 2003 Jan; 10(1):1-13. PubMed ID: 12489023 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells. Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496 [TBL] [Abstract][Full Text] [Related]
6. Cancer gene therapy using a novel secretable trimeric TRAIL. Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells. Hoffmann TK; Meidenbauer N; Müller-Berghaus J; Storkus WJ; Whiteside TL J Immunother; 2001; 24(2):162-71. PubMed ID: 11265774 [TBL] [Abstract][Full Text] [Related]
8. Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids. Ziske C; Etzrodt PE; Eliu AS; Gorschlüter M; Strehl J; Flieger D; Messmer D; Schmitz V; Gonzalez-Carmona MA; Sievers E; Brossart P; Sauerbruch T; Schmidt-Wolf IG Pancreas; 2009 Oct; 38(7):758-65. PubMed ID: 19546834 [TBL] [Abstract][Full Text] [Related]
9. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma. Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245 [TBL] [Abstract][Full Text] [Related]
10. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice. Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369 [TBL] [Abstract][Full Text] [Related]
11. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Itashiki Y; Harada K; Ferdous T; Yoshida H Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527 [TBL] [Abstract][Full Text] [Related]
12. Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector. Koppold B; Sauer G; Büning H; Hallek M; Kreienberg R; Deissler H; Kurzeder C Int J Oncol; 2005 Jan; 26(1):95-101. PubMed ID: 15586229 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma enhances interleukin 12 production in rheumatoid synovial cells via CD40-CD154 dependent and independent pathways. Kitagawa M; Suzuki H; Adachi Y; Nakamura H; Yoshino S; Sumida T J Rheumatol; 2001 Aug; 28(8):1764-71. PubMed ID: 11508577 [TBL] [Abstract][Full Text] [Related]
14. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
15. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand. Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas. Vardouli L; Lindqvist C; Vlahou K; Loskog AS; Eliopoulos AG Cancer Gene Ther; 2009 Nov; 16(11):848-60. PubMed ID: 19461675 [TBL] [Abstract][Full Text] [Related]
17. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694 [TBL] [Abstract][Full Text] [Related]